Clinical Trial Update: Effectiveness of Non-invasive Neuromodulation in Patients With Long-COVID [NA]

View source ↗

Summary

A clinical trial is evaluating the effectiveness of non-invasive neuromodulation for Long COVID (post-acute COVID-19 syndrome) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Universidad Rey Juan Carlos | Conditions: Long-COVID, Post-acute COVID-19 Syndrome | NA | Status: RECRUITING